Cipla Ltd.

Healthcare

04 September, 2015

Cipla to buy US-based InvaGen, Exelan for $550M

Indian drug major Cipla Ltd has agreed to acquire two US-based companies—InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc—for around $550 ......

Healthcare

21 July, 2015

Cipla to divest stake in consumer healthcare business to Fidelity Growth Partners

Mumbai-based drugmaker Cipla Ltd is roping in Fidelity Growth Partners India, a PE unit of asset management giant Fidelity, as ......

Healthcare

22 May, 2015

Cipla to acquire 51% stake in Ugandan firm Quality Chemicals for $30M

Mumbai-based drugmaker Cipla Ltd has agreed to acquire 51 per cent equity stake in Uganda-based Quality Chemicals Ltd (QCL) for ......

Healthcare

09 April, 2015

Cipla to buy Brazilian drug distributor Duomed

Mumbai-based drugmaker Cipla Ltd has inked a deal to buy Duomed Produtos Farmaceuticos Ltd, a two-year-old importer and distributor of ......

Healthcare

13 February, 2015

Cipla picking 60% stake in respiratory devices co Jay Precision Pharma for over $15M

Cipla Limited has signed a definitive agreement to acquire 60 per cent stake of Mumbai-based Jay Precision Pharmaceuticals Pvt Ltd ......

Healthcare

10 February, 2015

Cipla forms JV with existing partners Cooper Pharma and PHI in Morocco

Mumbai-based drug maker Cipla Limited has entered into a joint venture agreement with two of its existing business partners in ......

Healthcare

11 December, 2014

Cipla's subsidiary Meditab sells entire stake in Jiangsu pharma for $18.5M

Mumbai-based drug maker Cipla Limited has agreed to sell its entire stake in China-based pharmaceutical company Jiangsu Cdymax Pharmaceuticals for ......

Healthcare

06 October, 2014

Cipla signs pact to invest $37M for manufacturing unit in Iran with 75% stake

Mumbai-based drug maker Cipla Limited has inked a definitive agreement with its existing Iranian distributor for setting up a manufacturing ......

Healthcare

05 September, 2014

Cipla buying two plants owned by promoter's private firm Okasa for $17M

Medispray Laboratories Private Limited, a wholly owned subsidiary of Mumbai-based drugmaker Cipla Ltd, is acquiring two manufacturing units of private ......

Healthcare

18 July, 2014

Cipla acquires balance 75% stake in biotech firm Mabpharm

Mumbai-based drugmaker Cipla Ltd announced that Meditab Specialities Private Limited (MSPL), a wholly owned subsidiary of the company, has acquired ......